Annual CFO:
-$87.87M+$506.87M(+85.23%)Summary
- As of today, APLS annual cash from operations is -$87.87 million, with the most recent change of +$506.87 million (+85.23%) on December 31, 2024.
- During the last 3 years, APLS annual cash from operations has risen by +$475.26 million (+84.40%).
- APLS annual cash from operations is now -2450.76% below its all-time high of -$3.44 million, reached on December 31, 2013.
Performance
APLS Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFO:
$4.45M+$57.85M(+108.32%)Summary
- As of today, APLS quarterly cash from operations is $4.45 million, with the most recent change of +$57.85 million (+108.32%) on June 30, 2025.
- Over the past year, APLS quarterly cash from operations has increased by +$12.78 million (+153.30%).
- APLS quarterly cash from operations is now -96.87% below its all-time high of $141.98 million, reached on December 31, 2020.
Performance
APLS Quarterly Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
$4.49M+$12.78M(+154.15%)Summary
- As of today, APLS TTM cash from operations is $4.49 million, with the most recent change of +$12.78 million (+154.15%) on June 30, 2025.
- Over the past year, APLS TTM cash from operations has increased by +$412.77 million (+101.10%).
- APLS TTM cash from operations is now at all-time high.
Performance
APLS TTM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
APLS Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +85.2% | +153.3% | +101.1% |
| 3Y3 Years | +84.4% | +104.2% | +100.9% |
| 5Y5 Years | +58.4% | +104.7% | +101.2% |
APLS Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +85.2% | -87.0% | +102.5% | at high | +100.7% |
| 5Y | 5-Year | at high | +85.2% | -96.9% | +102.5% | at high | +100.7% |
| All-Time | All-Time | -2450.8% | +85.2% | -96.9% | +102.5% | at high | +100.7% |
APLS Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $4.45M(+108.3%) | $4.49M(+154.2%) |
| Mar 2025 | - | -$53.41M(-375.9%) | -$8.29M(+90.6%) |
| Dec 2024 | -$87.87M(+85.2%) | $19.36M(-43.2%) | -$87.87M(+57.2%) |
| Sep 2024 | - | $34.10M(+508.9%) | -$205.10M(+49.8%) |
| Jun 2024 | - | -$8.34M(+93.7%) | -$408.28M(+25.8%) |
| Mar 2024 | - | -$132.98M(-35.9%) | -$550.10M(+7.5%) |
| Dec 2023 | -$594.74M(-15.8%) | -$97.88M(+42.1%) | -$594.74M(+6.7%) |
| Sep 2023 | - | -$169.09M(-12.6%) | -$637.60M(-2.4%) |
| Jun 2023 | - | -$150.16M(+15.5%) | -$622.94M(-7.4%) |
| Mar 2023 | - | -$177.62M(-26.2%) | -$579.80M(-12.9%) |
| Dec 2022 | -$513.75M(+8.8%) | -$140.74M(+8.9%) | -$513.75M(-5.8%) |
| Sep 2022 | - | -$154.42M(-44.3%) | -$485.50M(+2.8%) |
| Jun 2022 | - | -$107.02M(+4.1%) | -$499.71M(+4.2%) |
| Mar 2022 | - | -$111.56M(+0.8%) | -$521.37M(+7.4%) |
| Dec 2021 | -$563.13M(-250.9%) | -$112.50M(+33.3%) | -$563.13M(-82.4%) |
| Sep 2021 | - | -$168.63M(-31.0%) | -$308.65M(-28.7%) |
| Jun 2021 | - | -$128.69M(+16.1%) | -$239.85M(-16.7%) |
| Mar 2021 | - | -$153.31M(-208.0%) | -$205.45M(-28.0%) |
| Dec 2020 | -$160.49M | $141.98M(+242.2%) | -$160.49M(+58.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$99.82M(-5.9%) | -$384.54M(-13.9%) |
| Jun 2020 | - | -$94.29M(+13.0%) | -$337.70M(-19.1%) |
| Mar 2020 | - | -$108.35M(-32.0%) | -$283.59M(-34.3%) |
| Dec 2019 | -$211.13M(-60.9%) | -$82.07M(-54.9%) | -$211.14M(-21.7%) |
| Sep 2019 | - | -$52.99M(-31.9%) | -$173.54M(-12.9%) |
| Jun 2019 | - | -$40.18M(-11.9%) | -$153.70M(-6.6%) |
| Mar 2019 | - | -$35.89M(+19.3%) | -$144.22M(-9.9%) |
| Dec 2018 | -$131.24M(-181.7%) | -$44.47M(-34.1%) | -$131.26M(-28.3%) |
| Sep 2018 | - | -$33.15M(-8.0%) | -$102.32M(-27.4%) |
| Jun 2018 | - | -$30.69M(-33.8%) | -$80.30M(-31.4%) |
| Mar 2018 | - | -$22.94M(-47.7%) | -$61.10M(-31.1%) |
| Dec 2017 | -$46.60M(-79.2%) | -$15.53M(-39.5%) | -$46.60M(-50.0%) |
| Sep 2017 | - | -$11.14M(+3.1%) | -$31.06M(-55.9%) |
| Jun 2017 | - | -$11.50M(-36.4%) | -$19.92M(-136.4%) |
| Mar 2017 | - | -$8.43M | -$8.43M |
| Dec 2016 | -$26.00M(-37.9%) | - | - |
| Dec 2015 | -$18.86M(-89.6%) | - | - |
| Dec 2014 | -$9.95M(-188.8%) | - | - |
| Dec 2013 | -$3.44M | - | - |
FAQ
- What is Apellis Pharmaceuticals, Inc. annual cash from operations?
- What is the all-time high annual cash from operations for Apellis Pharmaceuticals, Inc.?
- What is Apellis Pharmaceuticals, Inc. annual cash from operations year-on-year change?
- What is Apellis Pharmaceuticals, Inc. quarterly cash from operations?
- What is the all-time high quarterly cash from operations for Apellis Pharmaceuticals, Inc.?
- What is Apellis Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?
- What is Apellis Pharmaceuticals, Inc. TTM cash from operations?
- What is the all-time high TTM cash from operations for Apellis Pharmaceuticals, Inc.?
- What is Apellis Pharmaceuticals, Inc. TTM cash from operations year-on-year change?
What is Apellis Pharmaceuticals, Inc. annual cash from operations?
The current annual cash from operations of APLS is -$87.87M
What is the all-time high annual cash from operations for Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. all-time high annual cash from operations is -$3.44M
What is Apellis Pharmaceuticals, Inc. annual cash from operations year-on-year change?
Over the past year, APLS annual cash from operations has changed by +$506.87M (+85.23%)
What is Apellis Pharmaceuticals, Inc. quarterly cash from operations?
The current quarterly cash from operations of APLS is $4.45M
What is the all-time high quarterly cash from operations for Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. all-time high quarterly cash from operations is $141.98M
What is Apellis Pharmaceuticals, Inc. quarterly cash from operations year-on-year change?
Over the past year, APLS quarterly cash from operations has changed by +$12.78M (+153.30%)
What is Apellis Pharmaceuticals, Inc. TTM cash from operations?
The current TTM cash from operations of APLS is $4.49M
What is the all-time high TTM cash from operations for Apellis Pharmaceuticals, Inc.?
Apellis Pharmaceuticals, Inc. all-time high TTM cash from operations is $4.49M
What is Apellis Pharmaceuticals, Inc. TTM cash from operations year-on-year change?
Over the past year, APLS TTM cash from operations has changed by +$412.77M (+101.10%)